INX-315, a potent and selective CDK2 inhibitor, demonstrates robust antitumor activity in CCNE1-amplified cancers Alec G. Trub, John E. Bisi, Catherine Dietrich,Michael Taylor,Jay C. Strum,Shom Goel, Patrick J. RobertsCANCER RESEARCH（2023）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
